On 20 January 2026, Ropes & Gray’s Global Life Sciences Regulatory & Compliance team hosted the “Life Sciences Regulatory Outlook 2026” webinar. The session provided actionable insights into the most significant regulatory, compliance, and enforcement developments shaping the life sciences sector worldwide. The webinar provided a unique opportunity to share perspectives on anticipated policy priorities from Department of Health and Human Services (HHS) and Food and Drug Administration (FDA) in the United States, key legislative changes in Europe and China, and critical regulatory developments in Japan.
Read the full article: Navigating the Future: 2026 Life Sciences Regulatory Outlook – Global Strategies for Tackling Escalating Cross-Border Challenges //
Source: https://www.lexology.com/library/detail.aspx?g=2d5c246c-58bc-4fc0-a976-38a09f47dd21